bioAffinity Technologies Files 8-K
Ticker: BIAFW · Form: 8-K · Filed: Jul 31, 2025 · CIK: 1712762
Sentiment: neutral
Topics: 8-K, filing, corporate-events
Related Tickers: BIAF
TL;DR
BIAF filed an 8-K on 7/31 for events on 7/29 - check for updates.
AI Summary
bioAffinity Technologies, Inc. filed an 8-K on July 31, 2025, reporting events as of July 29, 2025. The filing includes information on "Other Events" and "Financial Statements and Exhibits." The company is incorporated in Delaware and its principal executive offices are located in San Antonio, Texas.
Why It Matters
This 8-K filing provides an update on significant corporate events and financial disclosures for bioAffinity Technologies, Inc., which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K current report and does not appear to contain any immediately alarming or high-risk information.
Key Players & Entities
- bioAffinity Technologies, Inc. (company) — Registrant
- July 29, 2025 (date) — Earliest event reported
- July 31, 2025 (date) — Filing date
- San Antonio, Texas (location) — Principal executive offices
FAQ
What specific "Other Events" are reported in this 8-K filing?
The filing indicates "Other Events" as an item, but the specific details of these events are not provided in the provided text snippet.
What "Financial Statements and Exhibits" are included with this 8-K?
The filing lists "Financial Statements and Exhibits" as an item, but the specific contents are not detailed in the provided text.
When was bioAffinity Technologies, Inc. incorporated, and in what jurisdiction?
bioAffinity Technologies, Inc. was incorporated in Delaware.
What is the business address of bioAffinity Technologies, Inc.?
The business address is 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217.
What is the SEC file number for bioAffinity Technologies, Inc.?
The SEC file number for bioAffinity Technologies, Inc. is 001-41463.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 31, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).